Di W - Search Results

1

Hybrid sequencing-based personal full-length transcriptomic analysis implicates proteostatic stress in metastatic ovarian cancer.

Jing Y, Zhang Y, Zhu H, Zhang K, Cai MC, Ma P, Shen P, Zhang Z, Shao M, Wang J, Yu M, Yin X, Zhang M, Hu Y, Chen D, Di W, Wang X, Zhuang G. Jing Y, et al. Among authors: di w. Oncogene. 2019 Apr;38(16):3047-3060. doi: 10.1038/s41388-018-0644-y. Epub 2019 Jan 7. Oncogene. 2019. PMID: 30617306

2

[Expression of human leucocyte antigen in ectopic endometrial tissue of endometriosis].

Xu H, Di W, Chen D. Xu H, et al. Among authors: di w. Zhonghua Fu Chan Ke Za Zhi. 2001 Aug;36(8):473-5. Zhonghua Fu Chan Ke Za Zhi. 2001. PMID: 11758182 Chinese.

3

Regulation of LC3-dependent protective autophagy in ovarian cancer cells by protein phosphatase 2A.

Yin X, Zhang N, Di W. Yin X, et al. Among authors: di w. Int J Gynecol Cancer. 2013 May;23(4):630-41. doi: 10.1097/IGC.0b013e3182892cee. Int J Gynecol Cancer. 2013. PMID: 23518861

4

Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer.

Wang Y, Liu P, Duan Y, Yin X, Wang Q, Liu X, Wang X, Zhou J, Wang W, Qiu L, Di W. Wang Y, et al. Among authors: di w. Biomaterials. 2014 Jan;35(3):983-92. doi: 10.1016/j.biomaterials.2013.09.062. Epub 2013 Oct 28. Biomaterials. 2014. PMID: 24176193

5

Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.

Liu T, Chen L, Sun X, Wang Y, Li S, Yin X, Wang X, Ding C, Li H, Di W. Liu T, et al. Among authors: di w. Tumour Biol. 2014 Mar;35(3):2427-36. doi: 10.1007/s13277-013-1322-x. Epub 2013 Nov 7. Tumour Biol. 2014. PMID: 24197980

6

[Risk of cervical cancer and precancerous diseases in the oral HPV carriers].

He YF, Zhang MY, Feng LD, Yin YH, Zhang R, Di W. He YF, et al. Among authors: di w. Zhonghua Fu Chan Ke Za Zhi. 2013 Aug;48(8):611-6. Zhonghua Fu Chan Ke Za Zhi. 2013. PMID: 24199928 Chinese.

7

High MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival time.

He YF, Zhang MY, Wu X, Sun XJ, Xu T, He QZ, Di W. He YF, et al. Among authors: di w. PLoS One. 2013 Dec 6;8(12):e79769. doi: 10.1371/journal.pone.0079769. eCollection 2013. PLoS One. 2013. PMID: 24324582 Free PMC article.

8

A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients.

Zhang M, He Y, Sun X, Li Q, Wang W, Zhao A, Di W. Zhang M, et al. Among authors: di w. J Ovarian Res. 2014 Feb 8;7:19. doi: 10.1186/1757-2215-7-19. J Ovarian Res. 2014. PMID: 24507759 Free PMC article.

9

MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.

Zhou X, Hu Y, Dai L, Wang Y, Zhou J, Wang W, Di W, Qiu L. Zhou X, et al. Among authors: di w. PLoS One. 2014 May 9;9(5):e96718. doi: 10.1371/journal.pone.0096718. eCollection 2014. PLoS One. 2014. PMID: 24816687 Free PMC article.

10

FOXM1 modulates cisplatin sensitivity by regulating EXO1 in ovarian cancer.

Zhou J, Wang Y, Wang Y, Yin X, He Y, Chen L, Wang W, Liu T, Di W. Zhou J, et al. Among authors: di w. PLoS One. 2014 May 13;9(5):e96989. doi: 10.1371/journal.pone.0096989. eCollection 2014. PLoS One. 2014. PMID: 24824601 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters